Inhibition of Oct 3/4 Mitigates the Cardiac Progenitor-derived Myocardial Repair in Infarcted Myocardium

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2015 Dec 26

PMID 26704423

Citations 4

Authors

Yu Tina Zhao

Jianfeng Du

Youfang Chen

Yaoliang Tang

Gangjian Qin

Guorong Lv

Shougang Zhuang

Ting C Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Recent evidence has demonstrated that cardiac progenitor cells play an essential role in the induction of angiomyogenesis in infarcted myocardium. We and others have shown that engraftment of c-kit(+) cardiac stem cells (CSCs) into infarcted hearts led to myocardium regeneration and neovascularization, which was associated with an improvement of ventricular function. The purpose of this study is aimed at investigating the functional role of transcription factor (TF) Oct3/4 in facilitating CSCs to promote myocardium regeneration and preserve cardiac performance in the post-MI heart.

Methods: c-kit(+) CSCs were isolated from adult hearts and re-introduced into the infarcted myocardium in which the mouse MI model was created by permanent ligation of the left anterior descending artery (LAD). The Oct3/4 of CSCs was inhibited by transfection of Oct3/4 siRNA, and transfection of CSCs with control siRNA serves as control groups. Myocardial functions were evaluated by echocardiographic measurement. Histological analysis was employed to assess newly formed cardiogenesis, neovascularization, and cell proliferations. Terminal deoxynucleotidyltransferase (TdT) nick-end labeling (TUNEL) was carried out to assess apoptotic cardiomyocytes. Real time polymerase chain reaction and Western blot were carried out to evaluate the level of Oct 3/4 in CSCs.

Results: Two weeks after engraftment, CSCs increased ventricular functional recovery as shown by a serial echocardiographic measurement, which is concomitant with the suppression of cardiac hypertrophy and attenuation of myocardial interstitial fibrosis. Suppression of Oct 3/4 of CSCs abrogated functional improvements and mitigated the hypertrophic response and cardiac remodeling. Transplantation of c-kit(+) CSCs into MI hearts promoted cardiac regeneration and neovascularization, which were abolished with the knockdown of Oct3/4. Additionally, suppression of Oct3/4 abrogated myocyte proliferation in the CSC-engrafted myocardium.

Conclusion: Our results indicate that CSCs-derived cardiac regeneration improves the restoration of cardiac function and is mediated through Oct 3/4.

Citing Articles

Effect of intravenous cell therapy in rats with old myocardial infarction.

Tang X, Wysoczynski M, Gumpert A, Li Y, Wu W, Li H Mol Cell Biochem. 2021; 477(2):431-444.

PMID: 34783963 PMC: 8896398. DOI: 10.1007/s11010-021-04283-2.

After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.

Bolli R, Tang X, Guo Y, Li Q Can J Physiol Pharmacol. 2020; 99(2):129-139.

PMID: 32937086 PMC: 8299902. DOI: 10.1139/cjpp-2020-0406.

The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation.

Liu Y, Fang Y, Su C, Hwang S, Liu P, Wu S Cell Death Discov. 2019; 5:59.

PMID: 30701091 PMC: 6349909. DOI: 10.1038/s41420-019-0143-0.

Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart.

Zhao Y, Wang J, Yano N, Zhang L, Wang H, Zhang S J Cell Physiol. 2018; 234(2):1671-1681.

PMID: 30171682 PMC: 6510276. DOI: 10.1002/jcp.27037.

References

Dimmeler S, Zeiher A, Schneider M . Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005; 115(3):572-83. PMC: 1052009. DOI: 10.1172/JCI24283. View

Xu X, Xu Z, Xu Y, Cui G . Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis. 2005; 16(4):245-55. DOI: 10.1097/00019501-200506000-00006. View

Berry M, Engler A, Woo Y, Pirolli T, Bish L, Jayasankar V . Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006; 290(6):H2196-203. DOI: 10.1152/ajpheart.01017.2005. View

Wu Y, Ip J, Huang J, Zhang L, Matsushita K, Liew C . Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006; 99(3):315-22. DOI: 10.1161/01.RES.0000235986.35957.a3. View

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Zeineddine D, Papadimou E, Chebli K, Gineste M, Liu J, Grey C . Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell. 2006; 11(4):535-46. DOI: 10.1016/j.devcel.2006.07.013. View

Stefanovic S, Puceat M . Oct-3/4: not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect. Cell Cycle. 2007; 6(1):8-10. DOI: 10.4161/cc.6.1.3633. View

Wei F, Scholer H, Atchison M . Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem. 2007; 282(29):21551-60. DOI: 10.1074/jbc.M611041200. View

Niwa H, Miyazaki J, Smith A . Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000; 24(4):372-6. DOI: 10.1038/74199. View

10.

Sutton M, Sharpe N . Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000; 101(25):2981-8. DOI: 10.1161/01.cir.101.25.2981. View

11.

St John Sutton M, Lee D, Rouleau J, Goldman S, Plappert T, Braunwald E . Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation. 2003; 107(20):2577-82. DOI: 10.1161/01.CIR.0000070420.51787.A8. View

12.

Oh H, Bradfute S, Gallardo T, Nakamura T, Gaussin V, Mishina Y . Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100(21):12313-8. PMC: 218755. DOI: 10.1073/pnas.2132126100. View

13.

Narmoneva D, Vukmirovic R, Davis M, Kamm R, Lee R . Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation. 2004; 110(8):962-8. PMC: 2754572. DOI: 10.1161/01.CIR.0000140667.37070.07. View

14.

Laugwitz K, Moretti A, Lam J, Gruber P, Chen Y, Woodard S . Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005; 433(7026):647-53. PMC: 5578466. DOI: 10.1038/nature03215. View

15.

Barile L, Messina E, Giacomello A, Marban E . Endogenous cardiac stem cells. Prog Cardiovasc Dis. 2007; 50(1):31-48. DOI: 10.1016/j.pcad.2007.03.005. View

16.

Hsieh P, Segers V, Davis M, Macgillivray C, Gannon J, Molkentin J . Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007; 13(8):970-4. PMC: 2754571. DOI: 10.1038/nm1618. View

17.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

18.

van Amerongen M, Engel F . Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med. 2008; 12(6A):2233-44. PMC: 4514102. DOI: 10.1111/j.1582-4934.2008.00439.x. View

19.

Stefanovic S, Abboud N, Desilets S, Nury D, Cowan C, Puceat M . Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol. 2009; 186(5):665-73. PMC: 2742180. DOI: 10.1083/jcb.200901040. View

20.

Kamp T, Lyons G . On the road to iPS cell cardiovascular applications. Circ Res. 2009; 105(7):617-9. PMC: 2771209. DOI: 10.1161/CIRCRESAHA.109.205740. View